ExtendicareTSX:EXE +0.23%81 Beneish M-Score is -2.42 as of Jun. 24, 2026. GuruFocus rates TSX:EXE with a GF Score™ of 81/100 and a GF Value™ of C$13.93 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Extendicare ranks worse than 63.29% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -2.42 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Extendicare's Beneish M-Score or its related term are showing as below:
TSX:EXE'
s Beneish M-Score Range Over the Past 10 Years
Min: -82.11 Med: -2.59 Max: -0.59
Current: -2.42
During the past 13 years, the highest Beneish M-Score of Extendicare was -0.59. The lowest was -82.11. And the median was -2.59.
Extendicare Beneish M-Score Related Terms
Extendicare Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Extendicare's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:EXE vs HCA, THC, DVA: Beneish M-Score Comparison
For the Medical Care Facilities subindustry, Extendicare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare Beneish M-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Extendicare's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Extendicare for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.9823
+
0.528 * 1
+
0.404 * 0.9663
+
0.892 * 1.1881
+
0.115 * 0.9991
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1.0005
+
4.679 * -0.032968
-
0.327 * 0.7612
=
-2.42
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(33.454 / (33.454 + 304.888))
/
(38.77 / (38.77 + 352.974))
=
0.098876
/
0.098968
=
0.9991
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(122.357 - 17.247
-
140.427)
/
1071.251
=
-0.032968
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Extendicare has a M-score of -2.42 suggests that the company is unlikely to be a manipulator.
Extendicare (TSX:EXE) has a Beneish M-Score of -2.42 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Extendicare and its competitors. According to the industry distribution chart, Extendicare ranks #400 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 63.3%.
Is Extendicare's Beneish M-Score too high?
Extendicare's current Beneish M-Score is -2.42. Based on the distribution chart, Extendicare ranks #400 out of 632 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Extendicare has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #400 out of 632 companies for Beneish M-Score. This places Extendicare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Extendicare and its competitors. Extendicare's current Beneish M-Score is -2.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (TSX:EXE) is currently considered Significantly Overvalued. The stock's GF Value™ is C$13.93, compared to a current price of C$34.13 — trading 145% above its estimated fair value. The current Beneish M-Score is -2.42. Extendicare's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Extendicare (TSX:EXE), the current Beneish M-Score is -2.42 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (TSX:EXE) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of C$34.13 is trading 145% above its estimated GF Value™ of C$13.93.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for TSX:EXE:
Beneish M-Score: -2.42
GF Value™: C$13.93 vs. price of C$34.13 (145% above fair value)
No single metric tells the full story. See the TSX:EXE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
81GF Score
Get the complete analysis for TSX:EXE
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:EXE has been successfully added to your 
